LITTLE COMPANY OF MARY — History
CCN 140179 | 3-year financial timeline | COVID resilience: 85/100
🛡️ Public data only — no PHI permitted on this instance.
$245M
Latest Revenue (FY2022)
+53.6%
Revenue CAGR (3yr)
-24.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $104M | $225M | $245M | +8.8% | +53.6% |
| Operating Expenses | $169M | $281M | $306M | +8.7% | +34.5% |
| Operating Margin | -62.8% | -24.9% | -24.9% | +0.1% | +0.0% |
| Net Income | $-65M | $-56M | $-61M | -8.7% | +0.0% |
| Licensed Beds | 220 | 220 | 227 | +3.2% | +1.6% |
| Total Patient Days | 36,689 | 60,937 | 56,403 | -7.4% | +24.0% |
| Medicare Day % | 35% | 32% | 31% | -5.1% | -5.7% |
| Medicaid Day % | 4% | 19% | 3% | -84.9% | -14.8% |
COVID Impact & Recovery
Resilience Score: 85/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +135.8% ($104M → $245M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+53.6%
This Hospital
+7.6%
State Avg
Latest Margin
-24.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $315M | -6.0% |
| FY2024 (proj) | $386M | 13.0% |
| FY2025 (proj) | $456M | 32.0% |